Jose Luis Zamorano

European Heart Journal · 2006–2021

A researcher in the Science corpus: 33 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from Jose Luis Zamorano's perspective

Ordered by how strongly the researchers Jose Luis Zamorano trusts endorse each paper. Same corpus, a different order for every researcher.

Cardiac dysfunction in the trastuzumab clinical trials experience. (Journal of Clinical Oncology)
Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. (Journal of Clinical Oncology)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. (New England Journal of Medicine)
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab (Circulation Cardiovascular Imaging)
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? (European Heart Journal)
Protective effects of carvedilol against anthracycline-induced cardiomyopathy. (Journal of the American College of Cardiology)
Congestive heart failure in patients treated with doxorubicin (Cancer)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. (New England Journal of Medicine)
Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. (Journal of the American College of Cardiology)

Their papers

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. (2007) — 1,524 citations
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. (2021) — 5,029 citations
2021 ESC/EACTS Guidelines for the management of valvular heart disease. (2021) — 4,456 citations
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations (2020) — 880 citations
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) (2019) — 4,847 citations
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope (2018) — 720 citations
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. (2018) — 1,696 citations
[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.] (2018) — 1,352 citations
2017 ESC/EACTS Guidelines for the management of valvular heart disease. (2017) — 4,280 citations
[2017 ESC/EACTS Guidelines for the management of valvular heart disease]. (2017) — 1,759 citations
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016) — 779 citations
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) — 4,502 citations
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016) — 2,566 citations
[2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. (2016) — 911 citations
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. (2016) — 993 citations
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous (2014) — 3,398 citations
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) — 2,183 citations
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) — 646 citations
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) — 2,440 citations
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (2013) — 3,948 citations